ATH 0.00% 0.4¢ alterity therapeutics limited

Ann: Prana accelerates PBT2 commercial developmen, page-6

  1. 1,616 Posts.
    re: Ann: Prana accelerates PBT2 commercial de... There are a few things that are key in biotech:
    - the technology/product
    - funding
    - being first to market

    This is significant news. Shaving off years to market means sooner profits and easier access to future trials in AD.

    US market will probably like the news. Price will go up x% on the NASDAQ, then the ASX will just copy the NASDAQ.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $0 51

Buyers (Bids)

No. Vol. Price($)
102 103948983 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31829254 17
View Market Depth
Last trade - 09.59am 29/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.